Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Esmolol for Propofol Injection Pain
NCT04356352Phase 3Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2020
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esmolol, sponsored by Wake Forest University Health Sciences. Started Sep 2020; status: terminated.
02
Drugs
esmolol
Beyond the preview
Go deeper on NCT04356352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356352.